NCT01026558View on ClinicalTrials.gov

A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
ObesityStaphylococcal Skin InfectionsStreptococcal Infections
Interventions
DRUG

Ceftobiprole

Ceftobiprole, 500 mg as single iv infusion over 2 hours

Sponsors
All Listed Sponsors
collaborator

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

lead

Basilea Pharmaceutica

INDUSTRY

NCT01026558 - A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients | Biotech Hunter | Biotech Hunter